Methotrexate
Introduction
Cancer patients undergoing chemotherapy may incur a debilitating side effect that may prompt dose reductions or discontinuation of the treatment regimen, ultimately leading to reduction in treatment efficacy. 1 Methotrexate (MTX) is an antimetabolite anticancer agent that has also shown efficacy in the treatment of rheumatoid disorders. Methotrexate alone or in combination with other anticancer agents is used in the treatment of breast cancer, leukemias, lymphomas, osteosarcoma, and several malignant brain tumors. 2 It is prescribed as a single dose in the management of ectopic pregnancy without adverse outcomes associated with ovary or in vitro fertilization. 3 Although MTX is well tolerated, however, its long-term use is often associated with major organ toxicity, and thus limits clinical applications. The toxicity of MTX in various organs such as the intestine, liver, kidney, testis and central nervous system has been reported. 4 Recent findings have shown that MTX-induced toxicity is associated with pro-inflammatory responses in animal models. 5, 6 The action mechanism of MTX inhibits dihydrofolate reductase and thymidylate synthase involved in the synthesis of DNA precursors such as thymidylates and purines. 7 The inhibition impairs DNA synthesis, DNA repair mechanism and replication during the S-phase of cell cycle in rapidly dividing cells including cancer cells and some normal dividing cells. 6 The underlying mechanism of MTX toxicity is unclear in the existing literature. 8 However, a number of mechanisms have been reported, including antioxidant defense deregulation and the activation of transcription factor, nuclear factor kappa B, to upregulate some genes responsible for the production of pro-inflammatory mediators. 6, 8 Accumulating evidence has implicated contribution of oxidative stress to MTX-induced organ toxicity. 3 Animal studies have shown that generation of reactive oxygen species (ROS) by MTX depletes first-line antioxidant enzyme systems, including reduced glutathione. 4, [9] [10] [11] [12] The resulting oxidative damage leads to lipid peroxidation and cell membrane damage in tissues. The intriguing evidence that synthetic antioxidants may play important role in pathogenesis has triggered a paradigm shift favoring natural products with antioxidant efficacy to reduce oxidative stress consequences in biological processes. 13 Virgin coconut oil (VCO) is a nutritional and medicinal food in the traditional coconut growing areas. It is an unrefined kernel oil obtained from fresh and mature coconut (Cocos nucifera) by mechanical or natural means, with or without the use of heat and without chemical bleaching and deodorizing. 14 It is being known for many beneficial health effects associated with its phenolic acids and flavonoid contents. 15 Phytochemical analysis found that p-coumaric and ferulic acids are the major potent phenolics in the VCO. 16 Previous studies found VCO to mitigate oxidative stress, dyslipidemia and inflammation in organs of animal models via antioxidant activities. [17] [18] [19] Although some agents have demonstrated antioxidant potential against MTX-mediated toxicity, the possible role of functional oils such as VCO that is affordable and amenable to daily diet need considerable attention. We sought to investigate whether dietary VCO supplementation has protective effects against MTX-induced oxidative stress and pro-inflammation in Wistar rats.
Methods

Chemicals
Methotrexate was purchased from the Morningside Healthcare Ltd, Leicester, UK. The assays for biochemical parameters (antioxidant enzymes and reduced glutathione) were carried out using commercial kits purchased from Randox Laboratory Ltd., UK. Thiobarbituric acid (TBA) was purchased from Hi Media Laboratories Pvt. Ltd, Mumbai, India. Commercial kits for nitric oxide, interleukin-6 and C-reactive protein were purchased from R&D Systems, USA and TULIP DIAGNOS-TICS, respectively. All other chemicals used were high-quality analytical-grade reagents.
Animals
Twenty-four adult male rats (about 7 weeks old) were purchased from the Veterinary Department, University of Nigeria, Nsukka, Enugu State, Nigeria. The animals were kept in the Animal House of the Department of Biochemistry, Ebonyi State University, Nigeria, in constant environmental conditions with 12 hr light/12 hr dark cycle and free access to clean water and commercial chow. All experimental protocols were in accordance with the guidelines and standards of animal's care approved by the National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory Animals. 20 
Virgin coconut oil
VCO was obtained from a dealer in Badagry, Lagos State, Nigeria. Evaluation of the procedures of VCO production showed that the VCO was made from fresh mature coconuts via traditional wet processing as reported by Nevin and Rajamohan. 21 Briefly, the viscous slurry obtained from the ground coconut meat was dissolved in clean water. The milky solution obtained was filtered through cheesecloth and the milky filtrate was left standing for 48 h to separate the creamy top and water layers. The sticky top layer was carefully removed and subjected to mild heating (50 • C) to remove moisture. The floating oil was gently scooped out and filtered into an airtight container and used for the present study.
Experimental design
Following 2 weeks of acclimatization, rats were randomized and grouped into 4 (n = 6 per group) and the treatment design was as follows:
Group 1 (normal control): received clean water and commercial chow for 17 days.
Group 2 (MTX control): received MTX (20 mg/kg body weight, ip) on day 14 only Group 3 (5% VCO diet + MTX): received 5% VCO (w/w) supplemented diet for 17 days + MTX (20 mg/kg body weight, ip) on day 14 only.
Group 4 (15% VCO diet): received 15% VCO (w/w) supplemented diet for 17 days + MTX (20 mg/kg body weight, ip) on day 14 only.
The body weight of each rat was determined and recorded on day 1, 14 and 17 using an electronic balance. At the end of the experimental period, blood samples were collected from all animals (fasted) via retro-orbital venous plexus by capillary tubes into plain sample bottles and allowed to clot. The clotted blood samples were centrifuged (3,000 g for 15 min) for separation of serum used for analysis of antioxidant enzymes, reduced glutathione, malondialdehyde and pro-inflammatory markers.
Biochemical analyses
Evaluation of biochemical parameters was carried out using standard commercially available kits. The antioxidant enzymes -superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and reduced glutathione (GSH) were analysed in serum samples with RANDOX kits following manufacturer's instructions. Lipid peroxidation marker, malondialdehyde (MDA) was estimated by the method of Wallin et al. 22 using Thiobarbituric acid (TBA) purchased from HiMedia Laboratories, Mumbai, India. Nitric oxide (NO) was analysed by commercial kit that contained Griess reagents (R&D Systems Inc., USA) according to the method of Green et al. 23 The level of interleukin-6 (IL-6) was estimated by ELISA method with assay kit from R&D Systems Inc., USA. Level of Creactive protein (CRP) was estimated according to the method of Andersen and McCarthy 24 as described in TULIP DIAGNOS-TICS kit for C-reactive protein. Fig. 1 
Statistical analyses
Data were analysed using SPSS software (Window version 22). The differences between groups were compared using oneway analysis of variance (ANOVA) followed by Tukey post hoc test. Data were represented as arithmetic mean ± standard error of mean (SEM). P < 0.05 was considered significant. 
Results
Effect of VCO supplementation on body weight of rats administered MTX
Effect of VCO supplementation on pro-inflammatory markers in MTX-induced toxicity in rats
Regarding pro-inflammatory markers, administration of MTX caused significantly increased (p < 0.01, p < 0.05) serum levels of IL-6, CRP and NO in rats. The pretreatment with dietary supplementation of VCO prominently (p < 0.01, p < 0.05) attenuated the increase in levels of IL-6, CRP and NO induced by MTX. However, it was observed that NO reduced insignificantly in rats fed 5% VCO supplemented diet compared to MTX control. Also, decrease in levels of these markers was more pronounced in rats fed 15% VCO supplemented diet.
Discussion
There is currently an unmet need for adjuvant therapy to modulate anticancer drug-induced toxicity during chemotherapy. Clinicians face the challenge of adverse effects emanating from treating patients with cancer therapies. 25 Methotrexate is efficacious and unique in that it can be administered safely in a multitude of dosing strategies. However, the limitation of MTX in clinical use is its side effects associated with oxidative stress and inflammatory responses. 4 Pharmacological interventions to mitigate MTX toxicities, including leucovorin rescue, have not substantially yielded desired results. 26 Abundant evidence suggests that the antioxidant phytochemicals in natural products may abrogate oxidative toxicity as found in MTX chemotherapy. [4] [5] [6] The present study aimed at investigating the protective effect of dietary VCO supplementation against the development of MTX-induced toxicity in rats.
In the present communication, acute-single dose of MTX considerably reduced the rat weight after 3 days of its administration. A number of systematic investigations on MTX toxicity found that MTX reduces body weight and organ weight insignificantly. 9, 27 According to Miyazono et al., rat body weight decreased at 24 h after the MTX administration and after 48 to 72 h increased. 28 In this study, significant decrease in body weight was found after 3 days of MTXinduced toxicity corroborating the recent experimental report by Abd-allah and Sharaf el-din. 29 However, the reduction in weight may be associated with oxidative stress-mediated necrosis, cirrhosis and fibrosis in major organs, including the liver. 30, 31 Several studies have implicated increased generation of reactive oxygen and nitrogen species and the consequent impairment in antioxidant defense systems in drug-induced toxicity. 32 Oxidative stress and lipid peroxidation has emerged to play a critical role in the pathogenesis of MTX-induced toxicity. Interestingly, the single administration of MTX (20 mg/kg) to rats induced prominent alterations in antioxidant defense mechanisms. It was found that MTX markedly depressed serum activities of SOD, CAT and GPx. Further, it significantly reduced the level of GSH, a non-enzymatic antioxidant that detoxifies H 2 O 2 and peroxides in association with GPx, glutathione reductase and glutathione-S-transferase. 9 SOD is an endogenous antioxidant enzyme that catalyzes dismutation of superoxide radical to H 2 O 2 . The antiradical activity of CAT is of great significance as it prevents the conversion of H 2 O 2 to the most damaging oxygen radical, hydroxyl radical (•OH), and concomitantly breakdown H 2 O 2 to water and molecular oxygen. GPx uses thiol-reducing power of GSH to reduce oxidized lipids, modulate hydroperoxides generation and protein targets of ROS. 33, 34 It is well known that damage to these antioxidant molecules exacerbate oxidative stress and lipid peroxidation confirmed in this study by distinct rise in MDA level. The MTX mechanism for reducing antioxidant defense is unclear; current literature suggests that it reduces GSH and cellular NADPH leading to amplified depression in other antioxidant enzymes. 35 Clinical manifestations consistent with oxidative stress and lipid peroxidation have been confirmed in humans. 36 Our findings are in consonance with previous reports that MTX administration triggers oxidative stress in various tissues. [2] [3] [4] [5] 8 In this study, serum activities of SOD, CAT and GPx, and GSH level were remarkably elevated in rats pretreated with VCO supplemented diet (5% and 15%) compared to MTX control. In corollary, lipid peroxidation was prevented as demonstrated by marked decrease in MDA levels. A growing body of evidence indicates VCO as emerging functional food oil due to reported beneficial health effects associated with its antioxidant potentials. 37 Recent reports have shown the antioxidant capacity of VCO via in vivo and in vitro studies. 12, 16 Although VCO is a saturated natural oil, its phytochemistry indicates the presence of potent natural antioxidants that could be responsible for the improvement in antioxidant defenses in the present study. 38 Moreover, there is a robust body of evidence that free radical generation and oxidative stress is capable of eliciting systemic inflammatory responses. 3, 39 A previous study reports that MTX induced small intestinal damage via mechanism of increased ROS and inflammation. 29 In the study, the inflamed intestine demonstrates oxidative stress and the proinflammatory cytokines, tumor necrosis factor-alpha (TNF-␣) and interleukin 1␤ (IL-1␤) were markedly elevated by MTX toxicity. In this study, the oxidative stress status induced by MTX significantly elevated the cytokine IL-6, the acute phase protein CRP and NO compared to normal control group. However, MTX has been implicated in the recruitment of immunocytes such as neutrophils and macrophages to tissues. In support, Alamir et al found that IL-1␤ and cytokine-induced neutrophil chemoattractant were markedly increased in MTX-treated rats. 40 NF-B in macrophages is a redox-sensitive transcription factor such that the increased oxidative stress induced by MTX might have activated it for the release of proinflammatory cytokine IL-6 and consequent production of CRP found elevated in the current study. 6, 8, 39, 40 Nitric oxide (NO) is a free radical gas with several pathophysiological functions. 18 It has been shown that MTX increases activity of inducible nitric oxide synthase (iNOS) resulting in increased NO pro- duction implicated in oxidative damage. 41 Our finding were in line with earlier studies that demonstrated proinflammatory activity of MTX. 29, 40, 41 Here, we have shown for the first time that VCO attenuates the proinflammation induced by MTX, as it significantly decreased IL-6, CRP and NO in rats administered MTX and pretreated with VCO (5% and 15%). The mechanism underlying the anti-inflammatory effect may be due to the VCO ability to reverse MTX-induced oxidative stress as indicated by increase in SOD, CAT, and GPx activities and GSH as well as evident decrease in MDA level in the current study. Secondly, dietary polyphenols are well reported to be modulators of inflammatory cascades to avert the cause of pathogenesis and demonstrate beneficial health effects. 42 Particularly, literature indicates that polyphenols triggers indirect mechanisms for the release of anti-inflammatory signaling molecules, such as IL-10 and decrease IL-1␤-induced NF-??B p65 DNA binding activity counteracting inflammation. 42, 43 Perceptibly, the bioactive polyphenols in VCO may modulate inflammatory networks resulting into decrease in inflammatory mediators found in this study. However, Hamsi et al had earlier reported that repeatedly heated VCO may not possess the anti-inflammatory effect. 17 The current beneficial health effects are in line with the previously reported antioxidant and anti-inflammatory effect of VCO against arthritis, cyclophosphamide, cardiovascular risk, insulin resistance and hepatic steatosis. 18, 19, [44] [45] [46] Further clinical studies would be necessary following the currently growing number of evidences supporting health benefits of VCO in preclinical models. There is a potential for VCO supplementation to be considered as a part of adjuvant strategies against side effects of MTX chemotherapy.
In conclusion, the present investigation demonstrated that the toxicity of MTX may be associated with impairment in antioxidant defense mechanism in addition to a perturbation of pro-inflammatory mediators which could be reversed by dietary supplementation of VCO. VCO supplementation may be beneficial in MTX chemotherapy by reducing oxidative stress and pro-inflammatory responses.
